Calls
2
Jessica Nix
Reporter, Bloomberg
Win Rate
50.0%
return
+2.6%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 13
$26.12
-2.7%
The obesity drug market is not a two-player race; at the J.P. Morgan healthcare conference, multiple companies including AstraZeneca and Roche were advancing obesity programs. Jessica Nix sees room for a third, fourth, and fifth player as companies try to enter the space, indicating a large and expanding market beyond Eli Lilly and Novo Nordisk.
Thematic ETFs
Long
Jan 12
$1067.71
+8.0%
The Nvidia-Eli Lilly partnership will build a San Francisco lab to use AI in drug discovery. Jessica Nix says this puts Eli Lilly at the forefront of AI-enabled pharma research, an area not really seen before, by automating research tasks and improving research and software. This is a positive catalyst for Eli Lilly.
GLP-1 / Obesity
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Jessica Nix has 2 trade ideas tracked on Buzzberg across 2 tickers since January 2026. Most covered: LLY, THNR.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
